Original article

CT angiography in evaluating resectability of hilar cholangiocarcinoma

Expand
  • a. Department of General Surgery, b. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received date: 2019-01-25

  Online published: 2019-04-25

Abstract

Objective To investigate the clinical value of abdominal CT angiography (CTA) in evaluating resectability of hilar cholangiocarcinoma. Methods The clinical data of 86 patients with hilar cholangiocarcinoma diagnosed pathologically in Department of Surgery this hospital were reviewed from January 2013 to December 2018. All patients underwent CT scan and CTA preoperatively for assessing of surgical resectability of hilar cholangiocarcinoma. Results A total of 53 patients (61.63%) had radical resection (R0 resection) in 86 patients with hilar cholangiocarcinoma. Remaining 33 patients underwent palliative surgery because of vascular invasion, distant lymph node metastasis or extensive intra-abdominal metastasis. CTA provided higher accuracy in evaluating major vascular invasion near the hepatic hilum with sensitivity 78.79%, specificity 92.45% and accuracy 87.21%. In evaluating lymph node metastasis near the hepatic hilum, CTA provided sensitivity only 42.86%. CTA evaluated distant metastasis with same sensitivity 42.86%. Conclusions CTA has certain advantages in evaluating major vascular invasion near the hepatic hilum. However, the sensitivity of CTA is poor in evaluating hilar lymph node metastasis and distant metastasis.

Cite this article

LI Min, TAO Ying, SONG Lujun, NI Xiaoling, SUO Tao, LIU Han, SHI Hongcheng, LIU Houbao . CT angiography in evaluating resectability of hilar cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2019 , 24(02) : 131 -134 . DOI: 10.16139/j.1007-9610.2019.02.010

References

[1] Razumilava N, Gores GJ.Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179.
[2] Miyata T, Okabe H, Chikamoto A, et al.A long-term survivor of hilar cholangiocarcinoma with resection of recurrent peritoneal dissemination after R0 surgery: a case report[J]. Surg Case Rep,2017,3(1):110z.
[3] Fisher AV, Ronnekleiv-Kelly SM.Surgical management of hilar cholangiocarcinoma[J]. Curr Surg Rep,2018,6(8) DOI: 10.1007/s40137-018-0210-0.
[4] Zhou Q, Guan Y, Mao L, et al.Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma[J]. HPB(Oxford),2018,20(12): 1163-1171.
[5] Li X, Zhang Y, Zhang Y.F-18-FDG PET/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma[J]. BMC Geriatr,2018,18(1):150.
[6] Bird NTE, Mckenna A, Dodd J, et al.Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma[J]. Br J Surg,2018, 105(11):1408-1416.
[7] 李相成, 季顾惟. 肝门胆管癌的根治性切除[J]. 外科理论与实践,2017,22(3):185-190.
[8] Wu X, Ni J, Zhang Z, et al.Preoperative evaluation of malignant perihilar biliary obstruction: negative-contrast CT cholangiopancreatography and CT angiography versus MRCP and MR angiography[J]. Am J Roentgenol,2015, 205(4):780-788.
[9] Ito K, Sakamoto Y, Isayama H, et al.The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma[J]. J Gastrointest Surg,2018,22(9):1528-1537.
[10] Choi J, Kim SG, Kim JS, et al.Comparison of endoscopic ultrasonography(EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer[J]. Surg Endosc,2010,24(6):1380-1386.
[11] Cha JH, Han JK, Kim TK, et al.Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability[J]. Abdom Imaging,2000,25(5): 500-507.
[12] Zhang H, Zhu J, Ke F, et al.Radiological imaging for assessing the respectability of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Biomed Res Int,2015,2015:497942.
[13] Toumi N, Abid H, Henchir S, et al.Role of magnetic re-sonance imaging in preoperative assessement of hilar cholangiocarcinoma[J]. Presse Med,2018,47(11-12 Pt 1):950-960.
Outlines

/